CENTAUR PHARMACEUTICALS PVT LTD

Overview

CENTAUR PHARMACEUTICALS PVT LTD is an active pharmaceutical ingredient (API) supplier with 34 active FDA Type II Drug Master Files, covering ALPRAZOLAM USP; AZITHROMYCIN DIHYDRATE USP; BRIMONIDINE TARTRATE USP; CHLORDIAZEPOXIDE HCL USP; CHLORDIAZEPOXIDE USP; CHLORZOXAZONE USP.

Core services & business areas

Active pharmaceutical ingredients supplied

Substances CENTAUR PHARMACEUTICALS PVT LTD is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

CENTAUR PHARMACEUTICALS PVT LTD holds 13 active (15 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• LINAGLIPTINActive2022-05-30
• CHLORDIAZEPOXIDE HCL USPActive2021-03-25
• ZALEPLON USPActive2013-09-25
• MILNACIPRAN HYDROCHLORIDEActive2012-12-03
• TETRABENAZINEActive2012-08-03
• ES-ZOPICLONE USPActive2012-06-07
• CHLORDIAZEPOXIDE USPActive2011-09-29
• BRIMONIDINE TARTRATE USPActive2010-06-09
• TIMOLOL MALEATE USPActive2010-03-11
• CLONAZEPAM USPActive2009-02-17
• LORAZEPAM USPActive2009-01-23
• OXAZEPAM USPActive2008-09-30
• ALPRAZOLAM USPActive2007-08-30
• NORTRIPTYLINE HCI USPInactive2011-10-07
• TEMAZEPAM USPInactive2011-10-03

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to CENTAUR PHARMACEUTICALS PVT LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.